Charles River Laboratories International Inc. has announced the second cohort of its Cell & Gene Therapy Incubator Program (CIP).

Charles River Laboratories International, Inc. (NYSE: CRL) today announced the second cohort of its Cell & Gene Therapy Incubator Program (CIP). Launched in December 2024, with the inaugural cohort ...

WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (CRL) today announced that four new directors will join its Board of Directors and that four long-time members of ...

The company reported Q4 2024 revenue of $1 billion, a 1.8% decline on an organic basis from the year prior, driven largely by lower Discovery and Safety Assessment (DSA) revenue. CEO Jim Foster ...

What Happened? Shares of lab services company Charles River Laboratories (NYSE:CRL) jumped 6.1% in the afternoon session ...

Lab services company Charles River Laboratories (NYSE:CRL) will be announcing earnings results this Wednesday before market hours. Here’s what you need to know. Charles River Laboratories beat ...

Charles River management believes that supplementary non-GAAP financial measures provide useful information to allow investors to gain a meaningful understanding of our core operating results and ...

ROCKVILLE, Md.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) and the Gates Institute at the University of Colorado Anschutz Medical Campus today announced a lentiviral ...

Charles River management believes that supplementary non-GAAP financial measures provide useful information to allow investors to gain a meaningful understanding of our core operating results and ...

Charles River Laboratories is expanding its biotech incubation offering to even earlier in the developmental pipeline. The CRO’s new Charles River incubator program will provide regulatory and quality ...

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced that, while working toward previously announced environmental goals, the Company has ...